Detecting Metastatic Breast Cancer: The Role of Scans and Emerging Blood Tests
Detecting Metastatic Breast Cancer: The Role of Scans and Emerging Blood Tests
Emerging Metastatic Breast Cancer Therapies: From CDK Inhibitors to SERDs and Beyond
Emerging Metastatic Breast Cancer Therapies: From CDK Inhibitors to SERDs and Beyond
Chronic GVHD Care: Examining the Efficacy and Safety of Axatilimab
Chronic GVHD Care: Examining the Efficacy and Safety of Axatilimab
Momelotinib vs. Ruxolitinib: Comparing Efficacy in Myelofibrosis and Anemia Patients
Momelotinib vs. Ruxolitinib: Comparing Efficacy in Myelofibrosis and Anemia Patients
How CRC Screenings Could Help Reduce Colonoscopy Backlog: A DDW Poster
How CRC Screenings Could Help Reduce Colonoscopy Backlog: A DDW Poster
Chronic GVHD Care: Identifying and Addressing Unmet Needs
Chronic GVHD Care: Identifying and Addressing Unmet Needs
Differentiating Biomarker-Driven First-Line Treatment Strategies in Metastatic Gastric/GEJ Cancers
Differentiating Biomarker-Driven First-Line Treatment Strategies in Metastatic Gastric/GEJ Cancers
October 25, 2024
11:00 AM - 11:45 AM ET
Differentiating Biomarker-Driven First-Line Treatment Strategies in Metastatic Gastric/GEJ Cancers
Differentiating Biomarker-Driven First-Line Treatment Strategies in Metastatic Gastric/GEJ Cancers
November 14, 2024
01:00 PM - 01:45 PM ET
Differentiating Biomarker-Driven First-Line Treatment Strategies in Metastatic Gastric/GEJ Cancers
Differentiating Biomarker-Driven First-Line Treatment Strategies in Metastatic Gastric/GEJ Cancers
December 02, 2024
03:00 PM - 03:45 PM ET
Bringing Treatment Into Focus: Biomarker-Driven First-Line Therapy for Metastatic Gastric/GEJ Cancers
Bringing Treatment Into Focus: Biomarker-Driven First-Line Therapy for Metastatic Gastric/GEJ Cancers
Navigating mCRC: A Closer Look at Biomarker Testing
Navigating mCRC: A Closer Look at Biomarker Testing
Tailored to Fit: Precision Medicine in Metastatic CRC
Tailored to Fit: Precision Medicine in Metastatic CRC
Considerations for Time-limited Treatment in 1L Treatment Selection Decisions
Considerations for Time-limited Treatment in 1L Treatment Selection Decisions
Helping Ensure Adequate Tissue Sampling Within the MDT
Helping Ensure Adequate Tissue Sampling Within the MDT
Managing Patients Within a Multidisciplinary Team Approach
Managing Patients Within a Multidisciplinary Team Approach
Pre-Testing: Working Together Toward Testing
Pre-Testing: Working Together Toward Testing
newswise.com
news-medical.net
medicalxpress.com
technologynetworks.com
eurekalert.org
medicalxpress.com
